STRA6 anticorps (Stimulated By Retinoic Acid 6) (PE)

Details for Product anti-STRA6 Antibody No. ABIN1712739, Fournisseur: Connectez-vous pour afficher
Antigène
  • MCOPCB8
  • MCOPS9
  • AI891933
  • RGD1307551
  • STRA6
  • im:7151282
  • wu:fc51h06
  • zgc:136689
  • mcops9
  • pp14296
  • stimulated by retinoic acid 6
  • stimulated by retinoic acid gene 6
  • stimulated by retinoic acid gene 6 homolog (mouse)
  • stimulated by retinoic acid gene 6 homolog
  • STRA6
  • Stra6
  • stra6
Alternatives
anti-Souris STRA6 anticorps pour Western Blotting
Reactivité
Humain, Souris, Rat (Rattus)
71
60
25
5
1
Hôte
Lapin
60
24
17
Clonalité
Polyclonal
Conjugué
Cet anticorp STRA6 est conjugé à/à la PE
8
8
6
5
5
5
3
3
3
3
3
2
2
1
1
1
1
1
1
Application
Flow Cytometry (FACS)
66
50
15
13
11
6
4
1
1
Options
Fournisseur
Connectez-vous pour afficher
Supplier Product No.
Connectez-vous pour afficher
Request

Ce produit gratuit

Envoyez-nous votre proposition de validation. J'aimerais valider ce produit

Savoir plus

Immunogène KLH conjugated synthetic peptide derived from human STRA6
Isotype IgG
Purification Purified by Protein A.
Autre désignation Stra6 (STRA6 Antibody Extrait)
Sujet

STRA6 is a 667 amino acid, multi-pass cell membrane protein. Stra6 functions as a cell-surface receptor for the complex retinol-retinol binding protein (RBP/RBP4). Ultimately increasing cellular retinol uptake from the retinol-RBP complex, Stra6 removes retinol from RBP/RPB4 and transports it across the plasma membrane, where it is metabolized. Stra6 is broadly expressed, with 4 named isoforms that exist as a result of alternative splicing events. Mutations in the gene encoding Stra6 cause Matthew-Wood Syndrome, also known as Spear Syndrome. This syndrome is characterized by anophtalmia, mild facial dysmorphism and malformations of the heart, lung and diaphragm. The Stra6 gene maps to chromosome 15q24.1.

Subcellular location: Extracellular


Synonyms: Stimulated by retinoic acid gene 6 protein homolog, STRA6_HUMAN.
ID gène 64220
Pathways Feeding Behaviour
Indications d'application FCM(1:20-100)
Commentaires

Exitation/Emission: 480,565nm/578nm

Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Stock -20 °C
Stockage commentaire Store at 4°C
Date de péremption 12 months